We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
700 14 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT

Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
700Buy Neptune Wellness Solutions for a double: Echelon cantechletter.comSultan-7 hours ago
699Neptune Achieves a Milestone with Completion of Phase II Expansion finance.yahoSultan-Wednesday
698Acasti presentation at NY Conference seekingalpha.comSultan-October 3
697Neptune Wellness Looks To Co-Develop CBD Products With International Flavors &amSultan-October 2
696Full interview: Acasti Pharma 'marching to the goal-line' with two PhaseSultan-October 2
695ACST Insider Filings canadianinsider.comSultan-October 2
694Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on TrSultan-September 30
693Neptune Wellness Solutions has big upside, GMP says cantechletter.comSultan-September 25
692Neptune Announces New U.S. Customer Relationships 24
691Acasti Investor Presentation Sep 10, 2019 seekingalpha.comSultan-September 18
690Wonder what impact this may have on NEPT? Nextleaf nabs new cannabis extractionE_K_S-September 18
689Acasti Pharma Receives Funding from the Government of Canada to Expand ProductioSultan-September 9
6882 Cannabis Extraction Companies to Buy Ahead of October fool.caSultan-September 7
687Chen discussing ACST at 12:45 mark .. youtube.comSultan-September 6
686New Neptune Wellness CEO Leverages Intellectual Property and Capital to Scale CaSultan-September 5
685Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global InvestmeSultan-September 5
6845 Ways to Invest in the Marijuana Craze With Ancillary Stocks 4. Look at extracSultan-August 30
683Neptune New Corporate Video youtube.comSultan-August 15
682CEO Investor Letter neptunecorp.comSultan-August 15
681Acasti Pharma, Inc. (ACST) CEO Janelle D' Alvise on Q1 2020 Results - EarninSultan-August 14
680Neptune Wellness Solutions, Inc. (NEPT) CEO Michael Cammarata on Q1 2020 ResultsSultan-August 14
679Neptune Reports Fiscal 2020 First Quarter Results 14
678Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020 acaSultan-August 14
677Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate Sultan-August 9
676He Was Expected To Fail Because Of His Dyslexia. He Then Made His First $1 MilliSultan-August 7
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):